TEVA•benzinga•
Samsung Bioepis And Teva Enter Partnership For Commercialization Of EPYSQLI In US; Samsung Bioepis Will Be Responsible For Development, Regulatory Registration, Manufacture And Supply Of The Product, While Teva Will Be Responsible For Commercialization
Summary
No summary available.
Original Article
Read the full article from the original source for complete details and context.
Read Full ArticleArticle published on January 10, 2025 by benzinga